Steven Cohen's AZN Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 926,370 shares of AstraZeneca PLC (AZN) worth $170.32 M, representing 0.19% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in AZN, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2020, adding 1.88 M shares. Largest reduction occurred in Q4 2022, reducing 1.64 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +641,686 | Add 225.40% | 926,370 | $183.86 |
| Q3 2025 | -558,092 | Reduce 66.22% | 284,684 | $153.44 |
| Q2 2025 | +248,940 | Add 41.92% | 842,776 | $139.76 |
| Q1 2025 | +57,021 | Add 10.62% | 593,836 | $147.00 |
| Q4 2024 | +536,815 | New Buy | 536,815 | $131.04 |
| Q3 2024 | -249,475 | Sold Out | 0 | $0.00 |
| Q2 2024 | +155,775 | Add 166.25% | 249,475 | $155.98 |
| Q1 2024 | -47,022 | Reduce 33.41% | 93,700 | $135.50 |
| Q4 2023 | +140,722 | New Buy | 140,722 | $134.70 |
| Q3 2023 | -164 | Sold Out | 0 | $0.00 |
| Q2 2023 | +164 | New Buy | 164 | $143.58 |
| Q1 2023 | -769,745 | Sold Out | 0 | $0.00 |
| Q4 2022 | -1.64 M | Reduce 68.01% | 769,745 | $135.60 |
| Q3 2022 | +1.42 M | Add 144.00% | 2.41 M | $109.68 |
| Q2 2022 | +319,090 | Add 47.85% | 985,990 | $132.14 |
| Q1 2022 | -217,800 | Reduce 24.62% | 666,900 | $132.68 |
| Q4 2021 | -334,844 | Reduce 27.46% | 884,700 | $116.50 |
| Q3 2021 | +317,532 | Add 35.20% | 1.22 M | $120.12 |
| Q2 2021 | -874,412 | Reduce 49.22% | 902,012 | $119.80 |
| Q1 2021 | -342,725 | Reduce 16.17% | 1.78 M | $99.44 |
| Q4 2020 | +1.88 M | Add 774.81% | 2.12 M | $99.98 |
| Q3 2020 | -105,453 | Reduce 30.33% | 242,241 | $109.60 |
| Q2 2020 | +72,670 | Add 26.42% | 347,694 | $105.78 |
| Q1 2020 | +275,024 | New Buy | 275,024 | $89.32 |
| Q3 2019 | -741,099 | Sold Out | 0 | $0.00 |
| Q2 2019 | -437,862 | Reduce 37.14% | 741,099 | $82.56 |
| Q1 2019 | +932,682 | Add 378.71% | 1.18 M | $80.86 |
| Q4 2018 | -132,421 | Reduce 34.97% | 246,279 | $75.96 |
| Q3 2018 | -1.02 M | Reduce 72.97% | 378,700 | $79.14 |
| Q2 2018 | -51,745 | Reduce 3.56% | 1.4 M | $70.22 |
| Q1 2018 | +990,168 | Add 214.04% | 1.45 M | $69.94 |
| Q4 2017 | -149,870 | Reduce 24.47% | 462,600 | $69.40 |
| Q3 2017 | +310,916 | Add 103.10% | 612,470 | $67.76 |
| Q2 2017 | +301,554 | New Buy | 301,554 | $68.18 |
| Q1 2017 | -338,000 | Sold Out | 0 | $0.00 |
| Q4 2016 | +338,000 | New Buy | 338,000 | $54.64 |
| Q2 2015 | -61,800 | Sold Out | 0 | $0.00 |
| Q1 2015 | -525,600 | Reduce 89.48% | 61,800 | $68.43 |
| Q4 2014 | -23,700 | Reduce 3.88% | 587,400 | $70.38 |
| Q3 2014 | +240,300 | Add 64.81% | 611,100 | $71.44 |
| Q2 2014 | +370,800 | Add 0.00% | 370,800 | $74.31 |
Steven Cohen's AstraZeneca PLC Investment FAQs
Steven Cohen first purchased AstraZeneca PLC (AZN) in Q2 2014, acquiring 370,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held AstraZeneca PLC (AZN) for 41 quarters since Q2 2014.
Steven Cohen's largest addition to AstraZeneca PLC (AZN) was in Q4 2020, adding 2,119,149 shares worth $211.87 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 926,370 shares of AstraZeneca PLC (AZN), valued at approximately $170.32 M.
As of the Q4 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.19% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in AstraZeneca PLC (AZN) was 2,405,830 shares, as reported at the end of Q3 2022.